SectorPharmaceutical
Established Date07/10/2005
Listing Date17/12/2010
ExchangeNASDAQ Stock Exchange
Full-time Employees73
Fiscal Year Ends31/12
Security TypeCommon stock
Office addressTwo Tower Place, 7th Floor, South San Francisco, California 94080
Business
IntroductionAssembly Biosciences, Inc., incorporated in Delaware on October 7, 2005, began operations in April 2007. The company is a biopharmaceutical company advancing clinical drug candidates that have the potential to improve the lives of millions of people living with chronic hepatitis B virus (HBV) worldwide, an early development program for highly recurrent genital herpes associated with herpes simplex virus (HSV-2) infection, a research program focused on the discovery of novel antiviral drugs for the treatment of destructive viral diseases, Including delta hepatitis virus (HDV) and transplantation-associated herpes virus.
